Cowen Raises Price Target on Amicus Therapeutics (FOLD) Following Announced Deal for Scioderm

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. MU
8. PFE
9. ACN
10. USO

Go back to Cowen Raises Price Target on Amicus Therapeutics (FOLD) Following Announced Deal for Scioderm

Amicus Therapeutics to Acquire Rare Disease Company Scioderm, Inc.

August 31, 2015 6:00 AM EDT

Scioderm's Lead Drug Candidate Zorblisa in Phase 3 Study for Rare Disease Epidermolysis Bullosa (EB) Granted FDA Breakthrough Therapy Designation

FDA Has Agreed to Rolling NDA Submission for Zorblisa Beginning in 4Q15

Acquisition Advances Amicus Vision to Create One of the World's Leading Rare Disease Biotechnology Companies

Conference Call Today at... More